Furthermore, PRDM5 expression in ESCC cells may affect WNT/β-catenin signaling pathways, thus further affect the ESCC cell proliferation, migration, and invasion capacity. This evidence concerns the gene PRDM5 and esophageal squamous cell carcinoma.